Gordon Sanghera
Founder bei OXFORD NANOPORE TECHNOLOGIES PLC
Vermögen: 16 Mio $ am 31.03.2024
Aktive Positionen von Gordon Sanghera
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Director/Board Member | 01.01.2005 | - |
Chief Executive Officer | 01.06.2005 | - | |
Founder | 01.01.2005 | - |
Karriereverlauf von Gordon Sanghera
Ehemalige bekannte Positionen von Gordon Sanghera
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Oxford NanoLabs Ltd.
Oxford NanoLabs Ltd. Medical SpecialtiesHealth Technology Oxford NanoLabs Ltd. develops nanopore technology to power a revolution in DNA analysis. It develops products for applications in genomics, pharmacogenomics and high thoroughput drug discovery as well as for the home defence and security sectors. The company was founded by Hagan Bayley in 2005 and is headquartered in Kidlington, UK. | Chief Executive Officer | - | 15.01.2009 |
Founder | - | 15.01.2009 | |
MediSense, Inc.
MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | Chief Tech/Sci/R&D Officer | - | - |
ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - | - |
Ausbildung von Gordon Sanghera
University of Cardiff | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Vereinigte Staaten | 3 |
Operativ
Chief Executive Officer | 2 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 4 |
Electronic Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
Private Unternehmen | 2 |
---|---|
MediSense, Inc.
MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | Health Technology |
Oxford NanoLabs Ltd.
Oxford NanoLabs Ltd. Medical SpecialtiesHealth Technology Oxford NanoLabs Ltd. develops nanopore technology to power a revolution in DNA analysis. It develops products for applications in genomics, pharmacogenomics and high thoroughput drug discovery as well as for the home defence and security sectors. The company was founded by Hagan Bayley in 2005 and is headquartered in Kidlington, UK. | Health Technology |
- Börse
- Insiders
- Gordon Sanghera
- Erfahrung